Literature DB >> 21642907

Long-term outcome in kidney transplant recipients over 70 years in the Eurotransplant Senior Kidney Transplant Program: a single center experience.

Claudia Boesmueller1, Matthias Biebl, Stefan Scheidl, Robert Oellinger, Christian Margreiter, Johann Pratschke, Raimund Margreiter, Stefan Schneeberger.   

Abstract

BACKGROUND: Kidney transplantation in the elderly is complicated by comorbidities and a higher incidence of death. The Eurotransplant Senior Program (ESP) has been established to allocate kidneys from older donors to the increasing number of older recipients. In this retrospective, single center data analysis, we compare the outcome of recipients older than 70 years with younger recipients transplanted under the ESP protocol.
METHODS: Between 1999 and 2009, a total of 83 kidneys were transplanted under the ESP protocol in Innsbruck and 19 of the recipients were older than 70 years (mean, 72.7 years). Cold ischemia time was kept short in both groups by giving preference to regional donor organs.
RESULTS: Patient survival at 1 and 5 years were 95% and 67% in the 70+ group and 94.4% and 82.6% in the 70- group. Graft survival was 95% and 52% at 1 and 5 years in the 70+ group and 94.4% and 79.0% in the 70- group. When censored for death, graft survival at year 1 and 5 were 100% and 82% in the 70+ group and 98.1% and 92.7% in the 70- group. The delayed graft function rate was high in both groups (36.8% and 41.1%, respectively). Morbidities were largely related to hemodynamic, oncologic, and infectious events. Cardiac failure was the major cause of death.
CONCLUSION: Relatively good results can be achieved with renal transplantation in patients older than 70 years under careful pretransplant evaluation and postoperative management of comorbidities.

Entities:  

Mesh:

Year:  2011        PMID: 21642907     DOI: 10.1097/TP.0b013e318222ca2f

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  7 in total

1.  Enhanced significance of donor-recipient age gradient as a prognostic factor of graft outcome in living donor kidney transplantation.

Authors:  Milljae Shin; Jae Berm Park; Choon Hyuck David Kwon; Jae-Won Joh; Suk-Koo Lee; Sung-Joo Kim
Journal:  World J Surg       Date:  2013-07       Impact factor: 3.352

2.  No consensus on physicians' preferences on vascular access management after kidney transplantation: Results of a multi-national survey.

Authors:  Bram M Voorzaat; Cynthia J Janmaat; Esther D Wilschut; Koen Ea Van Der Bogt; Friedo W Dekker; Joris I Rotmans
Journal:  J Vasc Access       Date:  2018-05-30       Impact factor: 2.283

3.  Two decades of the Eurotransplant Senior Program: the gender gap in mortality impacts patient survival after kidney transplantation.

Authors:  Thomas Schachtner; Natalie M Otto; Petra Reinke
Journal:  Clin Kidney J       Date:  2019-09-16

Review 4.  Pharmacokinetic and Pharmacodynamic Considerations in Relation to Calcineurin Usage in Elderly Kidney Transplant Recipients.

Authors:  Amelia R Cossart; Nicole M Isbel; Carla Scuderi; Scott B Campbell; Christine E Staatz
Journal:  Front Pharmacol       Date:  2021-04-12       Impact factor: 5.810

5.  Outcomes of Deceased Donor Kidney Transplantation in the Eurotransplant Senior Program with A Focus on Recipients ≥75 Years.

Authors:  Ilias Zompolas; Robert Peters; Lutz Liefeldt; Lukas J Lehner; Klemens Budde; Bernhard Ralla; Irena Goranova; Andreas Maxeiner; Markus H Lerchbaumer; Stephan R Marticorena Garcia; Martin Kanne; Thorsten Schlomm; Matthias R G Schulz; Frank Friedersdorff
Journal:  J Clin Med       Date:  2021-11-29       Impact factor: 4.241

6.  Risk Factors for Graft Failure and Death following Geriatric Renal Transplantation.

Authors:  Hyungjin Cho; Hoon Yu; Eunhye Shin; Young Hoon Kim; Su-Kil Park; Min-Woo Jo
Journal:  PLoS One       Date:  2016-04-13       Impact factor: 3.240

7.  Should We Perform Old-for-Old Kidney Transplantation during the COVID-19 Pandemic? The Risk for Post-Operative Intensive Stay.

Authors:  Philip Zeuschner; Urban Sester; Michael Stöckle; Matthias Saar; Ilias Zompolas; Nasrin El-Bandar; Lutz Liefeldt; Klemens Budde; Robert Öllinger; Paul Ritschl; Thorsten Schlomm; Janine Mihm; Frank Friedersdorff
Journal:  J Clin Med       Date:  2020-06-12       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.